Jun 19, 2007 by Brian LawlerVictory for Sanofi and Bristol-MyersSanofi gains a crucial legal victory for its top compound.
Jun 18, 2007 by Brian LawlerThe Third Time Isn't the Charm for EncysiveEncysive receives another approvable letter for its lead drug.
Jun 18, 2007 by Brian LawlerGilead Gets the PayoffGilead gets marketing approval for one of its drug candidates.
Jun 15, 2007 by Brian LawlerNeurocrine Moves AheadNeurocrine resubmits a marketing application for its lead drug.
Jun 15, 2007 by Brian LawlerAOB Supplements ItselfAmerican Oriental Bioengineering makes an acquisition.
Jun 15, 2007 by Brian LawlerEncysive's Date With Destiny ApproachesA decision on Encysive's lead drug is imminent.
Jun 15, 2007 by Brian LawlerIdenix Gets KnockedShares of Idenix drop slightly after the drug developer released clinical trial results this week.
Jun 14, 2007 by Brian LawlerDueling Fools: GlaxoSmithKline BullGlaxoSmithKline may be temporarily down, but it's not out.
Jun 14, 2007 by Brian LawlerDueling Fools: GlaxoSmithKline Bull RebuttalThe bull takes his chance to rebut.
Jun 13, 2007 by Brian LawlerTracking VertexVertex updates investors on the progress of its lead compound.
Jun 13, 2007 by Brian LawlerViroPharma Is on Its WayViroPharma completes preliminary enrollment in a study of one of its drug candidates.
Jun 13, 2007 by Brian LawlerNeurochem Collects the DataNeurochem hints at the data for its Alzheimer's disease drug candidate.
Jun 12, 2007 by Brian LawlerImClone Tries To Improve ErbituxIt's running trials to see if the drug can be used in earlier stages of cancer.
Jun 12, 2007 by Brian LawlerAdolor Is Still SwingingThe drugmaker bumps into the FDA as it pushes to do more testing of Entereg.
Jun 11, 2007 by Brian LawlerOverseas Action for SGPSchering gets an expanded label and begins marketing another drug overseas.
Jun 11, 2007 by Brian LawlerRenovis Is Still AroundRenovis continues development of its preclinical compounds.
Jun 11, 2007 by Brian LawlerJohnson & Johnson's Pretty PipelineJNJ highlights its pharmaceutical segment.
Jun 11, 2007 by Brian LawlerMore Air for AlkermesAlkermes brings another drug into clinic stage testing.
